Advent in exclusive negotiations on Zentiva

17 April 2018 - Deborah Wilkes

Archived

Private-equity firm Advent International has entered into exclusive negotiations to acquire Sanofi's European generics business Zentiva.

Click tags below for more information on topics:

Sanofi Consumer Healthcare Zentiva

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: